We developed a general method for the enrichment and identification of sequence-specific DNA-binding proteins. A well-characterized protein-DNA interaction is used to isolate from crude cellular extracts or fractions thereof proteins which bind to specific DNA sequences; the method is based solely on this binding property of the proteins. The DNA sequence of interest, cloned adjacent to the lac operator DNA segment is incubated with a lac repressor-beta-galactosidase fusion protein which retains full operator and inducer binding properties. The DNA fragment bound to the lac repressor-beta-galactosidase fusion protein is precipitated by the addition of affinity-purified anti-beta-galactosidase inmobilized on beads. Sequence-specific DNA-binding proteins are the mediators of many essential cell regulatory processes including transcription, initiation of DNA replication, and site-specific recombination. Studies in phage and bacterial genetics have allowed the identification and characterization of a number of procaryotic sequence-specific DNA-binding proteins. However, relatively few such proteins have been identified in eucaryotes, where classical genetic manipulations are cumbersome and biochemical analyses, are often hindered by smaller quantities of starting materials and by the apparent low abundance of many sequence-specific DNA-binding proteins.
Sequence-specific DNA-binding proteins are the mediators of many essential cell regulatory processes including transcription, initiation of DNA replication, and site-specific recombination. Studies in phage and bacterial genetics have allowed the identification and characterization of a number of procaryotic sequence-specific DNA-binding proteins. However, relatively few such proteins have been identified in eucaryotes, where classical genetic manipulations are cumbersome and biochemical analyses, are often hindered by smaller quantities of starting materials and by the apparent low abundance of many sequence-specific DNA-binding proteins.
In contrast, recombinant DNA technology coupled with improved methods for introducing in vitro manipulated DNA into eucaryotic cells has permitted the rapid identification of specific sequences involved in the regulation of gene expression, in the replication of viral DNAs, or in site-specific recombination (such as immunoglobulin gene rearrangement). Techniques for in vivo and in vitro footprinting can define the precise DNA sequences protected by unidentified factors (12) . In addition, the development of accurate systems for the in vitro transcription of cloned DNAs has helped define some of the template requirements necessary for faithful RNA synthesis (10, 17) . We devised a general method which uses specific DNA regulatory sequences identified by standard molecular biological approaches to detect and enrich the protein components which specifically interact with those sequences. The method uses a wellcharacterized specific and avid DNA-protein interaction, the binding of the lac repressor to the lac operator, as the basis for isolating specific factors from complex mixtures of protein. The DNA sequence of interest is cloned adjacent to a lac operator, and a DNA fragment containing both the operator and regulatory sequence is precipitated by the * Corresponding author.
sequential addition of both a lac repressor-beta-galactosidase fusion protein and immobilized antibodies directed against beta-galactosidase (Fig. 1A) . The specifically bound DNA fragment is then incubated with competitor DNA and an extract or fraction containing the factor(s) which recognizes the regulatory sequence of interest (Fig. 1B) . The immobilized DNA is recovered (Fig. 1C) , and the lac operator-containing DNA fragment with bound proteins is specifically released by the addition of isopropyl-p-Dthiogalactopyranoside (IPTG) which allosterically induces the lac repressor (Fig. 1D) . The eluate can then be analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
We demonstrated the specificity of this technique by isolating lambda repressor from whole cell extracts of Escherichia coli as a complex with the lambda operator region OL. In a single step the repressor is enriched from a minor cell constituent to approximately 90%o of the total protein. The applicability of this method to less well-characterized systems is shown by the identification of a 70,000-molecularweight (MW) peptide which binds to the promoter region of the yeast mitochondrial 14S rRNA gene. Partially purified preparations of yeast mitochondrial RNA polymerase, which support faithful transcription in vitro of yeast mitochondrial genes, contain a prominent 45,000-MW peptide as well as many minor bands which can be separated by polyacrylamide gel electrophoresis and visualized with silver staining (9, 15) . Although polyclonal antibodies directed against gel-purified 45,000-MW peptide inhibit polymerase activity, the enzyme was never purified to homogeneity, and there has been no (OL) . The resulting plasmid is designated pUC8-OL (Fig. 2) . Cleavage of pUC8-OL with restriction endonucleases PvuII and BglII produced three fragments. The smallest fragment is 733 base pairs and contains the lac operon regulatory sequences as well as OL and PL. Cleavage of pUC8 with PvuII produced two fragments; the smaller fragment is 301 base pairs (bp) and contains the lac operon regulatory sequences.
Four plasmids were used in the experiments identifying the mitochondrial promoter region DNA-binding protein (Fig. 3) . Two plasmids, pTB3'+29 and pTB3'-31, contain segments of the yeast mitochondrial 14S rRNA gene with deletions extending from a site in the body of the gene, in a 5' direction, to positions +29 and -31, respectively (2). The 5' border of the mitochondrial sequences in these plasmids is the SacII site at position -234 relative to the site of the initiation of transcription. The mitochondrial sequences are cloned between the BamHI (5') and EcoRI (3') sites of pUR250 (26 Binding of specific proteins. The binding procedure conveniently is divided into several steps. The lac repressor-betagalactosidase fusion protein was added to a solution of restriction endonuclease-digested plasmid DNA. This fusion protein retains full operator-binding capacity, inducibility, and beta-galactosidase activity (3, 21) . The restriction endonuclease chosen should leave both the lac operator and the DNA sequence of interest on the same fragment. Typically, 3 to 5 p.g of digested plasmid DNA is dissolved in lac repressor binding buffer, and 1 to 2.5 ,ug of lac repressor-beta-galactosidase fusion protein is added. To minimize the binding of non-operator DNA, it is essential to use sufficient operator-containing DNA to saturate the lac repressor-beta-galactosidase fusion protein.
Immunobeads were suspended in phosphate-buffered saline according to the recommendations of the manufacturer, and affinity-purified anti-beta-galactosidase (approximately 10 ,ug/ml of suspension) and 100 ,ug of bovine serum albumin per ml were added. This suspension was then incubated for 3 to (2) . Transcription reactions were allowed to proceed for 20 min at 20°C with periodic mixing. The reactions were stopped by the addition of SDS and EDTA to final concentrations of 1% and 10 mM, respectively. After centrifugation, the supernatants were removed, proteinase K was added to 100 ,ug/ml, and the mixtures were incubated at 37°C for 30 min. The reactions were extracted with phenol, and the aqueous phase was centrifuged on a Bio-Gel P6 column as described previously (23) . The excluded material was precipitated with ethanol, dried, counted for Cherenkov radiation, and analyzed by urea-polyacrylamide gel electrophoresis. Runoff transcripts synthesized by crude mitochondrial RNA polymerase and not subjected to the binding procedure were processed in a similar manner. (data not shown). It is interestng that several minor bands amounting to a small fraction of the total protein present in the eluates also appear to be binding specifically to the lambda sequences. The two largest of these minor bands comigrate with the two largest bands present in the wholecell extracts and hence can be identified as the beta and beta' subunits of E. coli RNA polymerase (4) .
RESULTS

Binding
Application of the binding technique to yeast mitochondria. Having demonstrated the efficacy of the method described above in a procaryotic model, we next sought to demonstrate its applicability to a less well-characterized system by identifying the protein(s) which binds to the promoter of the yeast mitochondrial 14S rRNA gene. Figure 3 shows the plasmnids used in these experiments. pTB3'+29 contains sufficient sequences to direct the in vitro synthesis of a specific runoff transcript initiated at position +1 of the 14S rRNA gene. pTB3'-31 does not allow detectable specific transcription of the 14S rRNA gene (2) . These plasmids differ only by 60 bp centered on position + 1 and containing nucleotides -10 to +2 which are essential for accurate in vitro transcription (2) . The mitochondrial sequences present in each plasmid consist of A-T-rich (approximately 95%) DNA with no other distinctive features (28) . Cleavage of each of these plasmids with PvuII generates a small fragment containing the entire mitochondrial insert and the lac operator; these fragments were immobilized on Immiunobeads via the lac repressor-beta-galactosidase fusion protein and anti-beta-galactosidase as described above. To eliminate the isolation of mitochondrial proteins potentially binding to sequences upstream from position -31, which are not required for specific transcription in vitro (2), the competitor plasmids retained the same upstream mitochondrial DNA sequences through position -234 as those retained by pTB3'-31 and pTB3'+29. The resulting plasmids pBR3'+29 and pBR3'-31 do not contain lac operator sequences and hence are not precipitated in the binding reaction.
Identification of a 70,000-MW peptide which binds to the mitochondrial 14S rRNA promoter region. The experiments shown in Fig. 5 directly identify and enrich a 70,000-MW peptide which specifically binds to the promoter region of the 14S rRNA gene. This peptide binds to promotercontaining DNA immobilized on the Immunobeads in the presence of a 50-fold mass excess of competitor DNA deleted of promoter sequences (Fig. 5, lane 4) . This peptide is not precipitated by immobilized promoter-deleted DNA (Fig. 5, lanes 2 and 3) . In addition, the binding of the peptide is eliminated when the competitor DNA in excess contains functional promoter sequences (Fig. 5, 4] .)
The specific binding of the 70,000-MW peptide to immobilized promoter sequences is dependent upon the stoichiometry of the immobilized and free promoter region sequences (Fig. 6) . As the molar ratio of bound pTB3' +29/competitor pBR3' +29 is decreased from 1/0 to 1/8 to 1/25 (Fig. 6, lanes 1 to 3, respectively) Immunobeads. Figure 7 shows portions of the eluates from the samples shown in Fig. 5 analyzed for DNA on a 1.5% agarose gel. Equal amounts of lac operator-containing restriction fragments and a small quantity of residual salmon sperm DNA are present in each sample. Also shown (Fig. 7 munobead pellets with proteins bound to the promoter region-containing DNA fragment were allowed to synthesize RNA directed from both bound and exogenously added templates. Faint specific runoff transcripts were produced from both the bound and added templates from binding reactions with immobilized promoter-containing DNA but not with immobilized promoter-deleted DNA (data not shown). Transcripts of 138 and 485 nucleotides, respectively, were directed by the bound PvuII fragment of pTB3'+29 and by added pBR3'+29 cleaved with HinclI. In addition, reactions containing pBR3'+29 cleaved with AatII produced the expected 101-nucleotide transcript. Less than 0.5% of the total polymerizing activity added to the binding reaction was recovered in the pellets (the binding reagents do not inhibit transcription, data not shown), which indicates that catalytic activity is not enriched by this specific binding assay. However, specific transcription in vitro is reconstituted by the method described in this paper with the additions of a fraction containing nonselective activity and a bound fraction prominently enriched for a 70,000-MW peptide (data not shown; see below).
DISCUSSION
Binding of lambda repressor: a demonstration of the method. We developed a method to identify proteins which bind to known regulatory DNA sequences. To verify the utility of this approach, we applied the procedure to extracts of E. coli containing the lambda repressor. In a single step, the lambda repressor is brought to approximately 90% of the total protein in the purified sample. In addition to the lambda repressor, it appears that a much smaller amount of E. coli RNA polymerase is also specifically precipitated by the technique described here. This could be due to specific binding of E. coli RNA polymerase to the lambda phage DNA sequences in PUC8-OL or to a weak association of polymerase with the lambda repressor bound to DNA. The increased amount of polymerase precipitated from extracts of induced cells containing the greatest amount of lambda repressor would favor the second possibility.
Is The mechanisms through which promoter specificity is conferred upon RNA polymerases can vary. Some RNA VOL. 5, 1985 polymerases, such as those found in some bacteriophage, possess intrinsic capacity for promoter site selection (6) . Most bacterial host RNA polymerases rely upon sigma factors which do not bind directly to DNA but do confer specificity upon core syzymes (5) . In eucaryotes, transcription factors such as TF IIIA and Sp-1 bind directly to specific sequences independently of RNA polymerase (8, 10) . If the 70,000-MW peptide proves to be a transcription factor, it would appear to be similar to other more well-characterized eucaryotic transcription factors in that it possesses specific DNA-binding properties in the absence of RNA polymerase. An alternative role for this 70,000-MW peptide in the reguldtion of 14S rRNA gene expression cannot be excluded at this time. It should be noted, however, that a similar consensus sequence is present at the initiation sites of transcription from a variety of mitochondrial genes (7i.
Small amounts of other peptides also may be enriched from the partially purified yeast mitochondrial RNA polymerase fraction. For instance, an 85,000-MW peptide is also visualized (Fig. 5, lane 4) (13, 20, 24, 29) .
(ii) This procedure theoretically can be scaled up approximately 100-to 1,000-fold and still be performed on a convenient laboratory scale. In all likelihood, the amount of available extract will be the limiting factor, not the amount or expense of required reagents. All of the reagents are either commercially available or easily prepared in the laboratory.
Potential applications, advantages, and limitations. The method described in this paper has many potential applications. It can be used with 35S-labeled cells for the radiographic identification of sequence-specific DNA-binding proteins from cell extracts or partially purified fractions. Much of the background staining seen in the results shown in this paper is from the added protein reagents and Kodavue staining and not from the crude mitochondrial RNA polymerase. Therefore, with radiolabeled extracts, this portion of the background becomes invisible.
Preliminary experiments with extracts of 135S]methioninelabeled mammnalian cells reveal the IPTG elution to be a very specific step which leaves nonspecifically absorbed proteins bound to the Immunobeads. If desired, the nonspecifically bound proteins can be eluted for electrophoretic analysis by the addition of SDS.
Factors recognizing transcriptional regulatory DNA sequences (possibly enhancers) should be identifiable with this method, even if specific for supercoiled DNA. Supercoiled plasmids can be readily and, in fact, preferentially precipitated with this method (data not shown). No covalent modification of the reversibly immobilized DNA is necessary with this technique; therefore, one can be certain of the integrity of the bound supercoiled molecules. Potentially, this technique can be coupled with the use of extrachromosomal vectors such as bovine papillomavirus (27) or yeast plasmids to rapidly identify regulatory proteins bound in vivo to DNA and to study chromatin structure. Additionally, the factors which regulate the expression of genes cloned into these extrachromosomal vectors may be isolated as part of a complex, formed in vivo, with their target sequences.
The technique described in this paper is designed to enrich and identify proteins solely on their ability to bind to specific DNA sequences. It provides no evidence for function other than DNA binding; hence, correlation with additional in vivo or in vitro evidence is required to assign a role to an enriched peptide in replication, recombination, or gene regulation. Because these experiments are performed in DNA excess to drive the equilibrium toward maximal specific DNA binding, techniques which require quantitative or near quantitative protection of specific sequences such as DNase footprinting cannot be performed directly on the eluted DNA-protein complex. Additional analysis of the specific protein may require elution from its target sequence and removal of nucleic acid. Additional advantages and limitations of this technique will be defined by applications such as those outlined above.
